Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 26/08/2011
PIL Bonefos Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 10/05/2011 and displayed until 26/08/2011
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 15/03/2011 and displayed until 10/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 25/11/2010 and displayed until 15/03/2011
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 24/06/2008 and displayed until 25/11/2010
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
  • Change of licence holder
  • Change to MA holder contact details
Updated on 03/08/2007 and displayed until 24/06/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 08/12/2006 and displayed until 03/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 05/01/2006 and displayed until 08/12/2006
Reasons for adding or updating:
  • Change of Marketing Authorisation Holder
Updated on 01/07/2003 and displayed until 05/01/2006
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Update to PIL
Updated on 28/09/2000 and displayed until 01/07/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sodium clodronate